Dusan Sajic

526 total citations
17 papers, 400 citations indexed

About

Dusan Sajic is a scholar working on Immunology, Dermatology and Epidemiology. According to data from OpenAlex, Dusan Sajic has authored 17 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Dermatology and 6 papers in Epidemiology. Recurrent topics in Dusan Sajic's work include Autoimmune Bullous Skin Diseases (3 papers), Dermatology and Skin Diseases (3 papers) and Immune Response and Inflammation (3 papers). Dusan Sajic is often cited by papers focused on Autoimmune Bullous Skin Diseases (3 papers), Dermatology and Skin Diseases (3 papers) and Immune Response and Inflammation (3 papers). Dusan Sajic collaborates with scholars based in Canada, United States and Austria. Dusan Sajic's co-authors include Kenneth L. Rosenthal, Ali A. Ashkar, Navkiran Gill, Beata Gajewska, Martin R. Stämpfli, Manel Jordana, Clinton S. Robbins, Filip K. Świrski, Michael J. McCluskie and Felipe B. Cerci and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

Dusan Sajic

15 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dusan Sajic Canada	9	223	150	72	67	47	17	400
Ann McIlgorm United Kingdom	6	491 2.2×	96 0.6×	53 0.7×	155 2.3×	27 0.6×	7	698
Karlheinz Enssle Germany	12	204 0.9×	100 0.7×	32 0.4×	123 1.8×	74 1.6×	18	426
José María Ortiz Salvador Spain	11	82 0.4×	81 0.5×	182 2.5×	53 0.8×	71 1.5×	48	333
Andreas Dorfmüller Germany	4	315 1.4×	123 0.8×	43 0.6×	79 1.2×	43 0.9×	4	561
Jorge Magdaleno‐Tapial Spain	11	84 0.4×	90 0.6×	130 1.8×	51 0.8×	17 0.4×	69	319
Frane Banović United States	13	94 0.4×	101 0.7×	124 1.7×	24 0.4×	93 2.0×	58	402
Hideki Kuga Japan	10	293 1.3×	84 0.6×	20 0.3×	132 2.0×	31 0.7×	12	443
Chuan En Lam Australia	5	259 1.2×	117 0.8×	28 0.4×	286 4.3×	79 1.7×	6	501
Melissa A. Gessner United States	7	244 1.1×	113 0.8×	28 0.4×	89 1.3×	26 0.6×	8	461
Lauren Lilly United States	6	261 1.2×	142 0.9×	28 0.4×	117 1.7×	32 0.7×	7	509

Countries citing papers authored by Dusan Sajic

Since Specialization

Citations

This map shows the geographic impact of Dusan Sajic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dusan Sajic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dusan Sajic more than expected).

Fields of papers citing papers by Dusan Sajic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dusan Sajic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dusan Sajic. The network helps show where Dusan Sajic may publish in the future.

Co-authorship network of co-authors of Dusan Sajic

This figure shows the co-authorship network connecting the top 25 collaborators of Dusan Sajic. A scholar is included among the top collaborators of Dusan Sajic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dusan Sajic. Dusan Sajic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Turchin, Irina, et al.. (2025). Brodalumab for Plaque Psoriasis in the Canadian Real-World Setting: A Retrospective Cohort Analysis of up to 4 Years. Dermatology and Therapy. 15(4). 949–962.

Amiri, Mojgan, et al.. (2025). Combined and Hybrid Treatments of Hyaluronic Acid (HA) and Calcium Hydroxylapatite (CaHA): A Systematic Review of Mechanisms of Action, Aesthetic Effectiveness, Satisfaction, and Safety Profile. Aesthetic Plastic Surgery. 49(19). 5292–5313.

Sajic, Dusan, et al.. (2024). Real-World Effectiveness of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Canada. Journal of Cutaneous Medicine and Surgery. 29(2). 137–142. 1 indexed citations

Sajic, Dusan, et al.. (2023). IgA pemphigus following COVID-19 vaccination: A case report. SHILAP Revista de lepidopterología. 11. 2050313X231181022–2050313X231181022. 6 indexed citations

Sajic, Dusan, et al.. (2023). Cryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma. Journal of Drugs in Dermatology. 22(12). 1166–1171. 1 indexed citations

Bohdanowicz, Michal & Dusan Sajic. (2018). Refractory Palmoplantar Pustular Psoriasis Treated With High-Dose Ustekinumab After Initial Failure. Journal of Cutaneous Medicine and Surgery. 23(1). 102–104. 2 indexed citations

Boull, Christina, Sara Hylwa, Dusan Sajic, et al.. (2016). Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation. The Journal of Pediatrics. 173. 242–244. 10 indexed citations

Qiang, Judy, et al.. (2015). Serpiginous mycosis fungoides in a 21-year-old man. JAAD Case Reports. 1(2). 82–84. 1 indexed citations

Dupuis, Lucie, Pekka Kannus, Roberto Mendoza‐Londono, et al.. (2015). Buschke-Ollendorff syndrome: a novel case series and systematic review. British Journal of Dermatology. 174(4). 723–729. 19 indexed citations

10.

Alavi, Afsáneh, Dusan Sajic, Felipe B. Cerci, et al.. (2014). Neutrophilic Dermatoses: An Update. American Journal of Clinical Dermatology. 15(5). 413–423. 46 indexed citations

11.

Sajic, Dusan, J. Archibald, & Christian Murray. (2014). Surface Anatomy of the Ear. Journal of Cutaneous Medicine and Surgery. 18(2). 137–140. 1 indexed citations

12.

Sajic, Dusan, et al.. (2012). A look at epidermal barrier function in atopic dermatitis: physiologic lipid replacement and the role of ceramides.. PubMed. 17(7). 6–9. 29 indexed citations

13.

McCluskie, Michael J., et al.. (2005). Treatment of intravaginal HSV-2 infection in mice: A comparison of CpG oligodeoxynucleotides and resiquimod (R-848). Antiviral Research. 69(2). 77–85. 33 indexed citations

14.

Sajic, Dusan, et al.. (2005). Mucosal delivery of CpG oligodeoxynucleotides expands functional dendritic cells and macrophages in the vagina. Immunology. 114(2). 213–224. 23 indexed citations

15.

Ashkar, Ali A., et al.. (2004). Toll‐Like Receptor (TLR)–3, but Not TLR4, Agonist Protects against Genital Herpes Infection in the Absence of Inflammation Seen with CpG DNA. The Journal of Infectious Diseases. 190(10). 1841–1849. 121 indexed citations

16.

Sajic, Dusan, et al.. (2003). Parameters of CpG oligodeoxynucleotide‐induced protection against intravaginal HSV‐2 challenge. Journal of Medical Virology. 71(4). 561–568. 35 indexed citations

17.

Świrski, Filip K., Dusan Sajic, Clinton S. Robbins, et al.. (2002). Chronic Exposure to Innocuous Antigen in Sensitized Mice Leads to Suppressed Airway Eosinophilia That Is Reversed by Granulocyte Macrophage Colony-Stimulating Factor. The Journal of Immunology. 169(7). 3499–3506. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact